Rapid Response Teams - How and Who?
This will be an investigator initiated One-sided blinded Randomized Clinical Trial. The study will examine the composition of the Rapid Response Team (RRT). the investigators will examine to see if a Critical Care Outreach Team (CCOT) consisting of an ICU-Nurse and a general ward physician and nurse are non-inferior to
| Condition(s) | Hospital Rapid Response Team, Early Warning Score, Intensive Care Units |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This will be an investigator initiated One-sided blinded Randomized Clinical Trial. The study will examine the composition of the Rapid Response Team (RRT). the investigators will examine to see if a Critical Care Outreach Team (CCOT) consisting of an ICU-Nurse and a general ward physician and nurse are non-inferior to a Medical Emergency Team (MET) consisting of an ICU-Doctor and ICU Nurse as well as a general ward physician and nurse. The randomization will be done using an Analogue randomization sequence using sealed opaque envelopes with central randomization.The experimental intervention will be the CCOT. The statistical analyses will be done on the primary outcomes in the intention to treat population and on the secondary outcomes on an per-protocol basis exempting those with protoco |
| Who can participate | Inclusion Criteria: * Admitted to any general ward of the hospital AND * Aged ≥ 18 years AND * In need of RRT attention Exclusion Criteria: * Age \< 18 * Admitted to the delivery ward * Admitted to any ward in the anesthetic department * ICU * High Dependency Unit * Post Operation Department * Operating Theatre * Same Day Admissions - Surgery Ward * Not admitted at the time of call * Evaluation track in Emergency department (prior to being seen by a doctor) * Out-Patient departments * X-ray department * Any patient who cannot be randomized at the time of call |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Nordsjaellands Hospital |
| Locations | Hillerød, Danmark, Denmark |
| Start date | 2021-09-01 |
| NCT ID | NCT04507737 |
| Official listing | https://clinicaltrials.gov/study/NCT04507737 |